Teva Pharmaceuticals Retirement Savings Plan (Puerto Rico) — Form 5500 plan (Teva Pharmaceuticals)
Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Teva Pharmaceuticals Retirement Savings Plan (Puerto Rico) is a benefit plan reported by Teva Pharmaceuticals under EIN 22-1734359 and plan number 002. The latest loaded filing year is 2023. The filing reports 68 participants and $5,968,354 in end-of-year plan assets, where available in the loaded dataset.
Form 5500 plan profile · 2023
Key reported metrics
Net assets (EOY)$6MPlan net assets, end of year$5,968,354
Participants68Covered participants reported
Assets / participant$87.8KComputed: assets ÷ participants$87,770 (computed)
Provider compensationNone reported
- Plan sponsor
- Teva Pharmaceuticals
- EIN
- 22-1734359
- Plan number
- 002
- Plan type
- 2
- Location
- Parsippany, NJ
- Latest filing year
- 2023
Form 5500 filing history
| Filing year | Participants | Schedules | Filing |
|---|---|---|---|
| 2023 | 68 | I | 20240925122310NAL0005442963001 |
Schedule I · 2023
Reported financial statement
Reported figures as filed, in whole dollars. Only fields the filing reports are shown; others are marked not reported.
Reported balance (end of year)$6M total assets
Net assets$6MLiabilities—
Full reported line items
Net assets
- Total assets (EOY)
- $5,968,354
- Net assets (EOY)
- $5,968,354
- Net assets (BOY)
- $5,613,704
Income & contributions
- Total income / additions
- $750,470
Expenses & distributions
- Benefits paid
- $385,724
- Total expenses
- $395,820
- Net increase / (decrease)
- $354,650
Service provider compensation (Schedule C)
No Schedule C service provider compensation is loaded for this plan yet.